Answers are grounded in this paper and cite their sources.
Cytomegalovirus (CMV) is a leading cause of congenital infection and neonatal morbidity worldwide. Viral genetic variability, particularly in envelope glycoproteins, may influence disease severity, yet data from regions with high maternal seroprevalence, such as Tunisia, remain limited. This study aimed to characterize the distribution of CMV envelope glycoprotein genotypes (gB, gN, and gO) in infants with congenital CMV infection (cCMV) and postnatal or unproven congenital CMV infection (pCMV), and to explore their associations with viral load and clinical manifestations. We conducted a retrospective, single-center study of 124 CMV-infected infants (24 cCMV, 100 pCMV). CMV viral load was quantified in urine and plasma using real-time PCR. Genotyping of gB, gN, and gO was performed by multiplex nested PCR. Groups were compared using chi-square or Fisher’s exact tests and Mann–Whitney U tests, while exploratory associations between genotypes, viral load, and clinical outcomes were assessed using multivariable logistic regression. Urinary viral load was significantly higher in cCMV than in pCMV (median 5.75 vs. 4.86 log₁₀ copies/mL; p < 0.001), whereas plasma viral loads did not differ significantly ( p = 0.307). Genotype distributions were broadly similar between groups: gB2 was the most frequent genotype in cCMV (41.7%). The distribution of gO genotypes differed significantly between groups ( p = 0.040), with mixed gO infections being the most frequent category in both groups (29.2% in cCMV vs. 60.0% in pCMV). In the combined cohort, the gN4 genotype was associated with increased risk of CNS damage (aOR = 7.49, 95% CI 1.72–32.62; p = 0.007), jaundice (aOR = 4.06, 95% CI 1.29–12.86; p = 0.017), liver damage (aOR = 3.37, 95% CI 1.31–8.66; p = 0.012), and severe CMV disease (aOR = 2.78, 95% CI 1.12–6.88; p = 0.027), whereas gO-1 was inversely associated with thrombocytopenia (aOR = 0.13, 95% CI 0.06–0.75; p = 0.016). The gN4 genotype was associated with CNS involvement, liver involvement, jaundice, and severe CMV disease, but these associations do not establish causality or clinical utility. Urinary viral load was higher in infants with cCMV but was not significantly associated with severe CMV disease. Larger prospective multicenter studies are needed to confirm these findings and clarify the clinical relevance of CMV genetic variability.
No takes yet. Share an insight, caveat, or question.
Handous et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: